Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented City Therapeutics in the transaction. City Therapeutics, a biopharmaceutical company, announced raising $135 million in Series A financing...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised Replicate Bioscience on the deal. Replicate Bioscience, a San Diego-based biotechnology company, announced its licensing agreement to collaborate with Precision NanoSystems, a developer of...
You must be a Standard 1 Year member to access this content.
Hengeler Mueller advised Meta on the merger investigation of the German Federal Cartel Office while Gunderson Dettmer represented Kustomer. The German Federal Cartel Office approved Meta...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised The Athletic on its sale to The New York Times Company, assisted by Borden Ladner Gervais LLP and...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised OutboundEngine on the deal. OutboundEngine, an Austin-based marketing automation software company, announced its acquisition by Elm Street Technology, a...
You must be a Standard 1 Year member to access this content.
